Svar Life Science

November 26, 2024

Live Cell-Based Assays

Wieslab has over 10 years of experience analyzing antibodies against AQP4 and MOG in serum and CSF.

We are now expanding our test portfolio by offering Live Cell-Based Assays (CBA) in serum for these antibodies.

November 26, 2024

Live Cell-Based Assays

Wieslab has over 10 years of experience analyzing antibodies against AQP4 and MOG in serum and CSF.

We are now expanding our test portfolio by offering Live Cell-Based Assays (CBA) in serum for these antibodies.

Our new analyses offer several advantages:

  • Improved diagnostic capabilities for NMOSD and MOGAD
  • Very high sensitivity with maintained specificity for NMO (AQP4) and MOGAD (MOG)
  • Results within just 1-2 weeks

Our Live CBA analyses are available as:

View the panel